Form 4 Filing for Camp4 Therapeutics Corp - Insider Transaction

Michael F. MacLean, a director at Camp4 Therapeutics Corp, acquired 56,000 stock options on April 1, 2026. These options, with an exercise price of $4.46, are exercisable and expire on March 31, 2036. The underlying securities are 56,000 shares of Common Stock. The options vest in equal monthly installments over three years, commencing from the grant date. Following this transaction, MacLean directly owns 56,000 shares of Common Stock underlying the vested options.